Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line
- PMID: 9585065
- DOI: 10.1016/s0304-3835(98)00004-4
Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line
Abstract
Canine and human osteosarcoma are very similar with respect to clinical presentation, radiological and histopathological features, metastatic rate and pattern and response to therapy. For these reasons, canine osteosarcoma is a useful intermediate model for the disease in humans. Overexpression of P-glycoprotein, the product of the MDR1 gene, is the most important predictor of an adverse clinical course in human patients with osteosarcoma. Exposure of canine osteosarcoma cells to doxorubicin resulted in overexpression of MDR1 mRNA and P-glycoprotein. Furthermore, these cells failed to accumulate doxorubicin intracellularly and were less sensitive to vincristine-induced cytotoxicity as compared to parental cells.
Similar articles
-
Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.J Bone Joint Surg Am. 2000 Jul;82-A(7):963-9. doi: 10.2106/00004623-200007000-00008. J Bone Joint Surg Am. 2000. PMID: 10901311
-
Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.J Natl Cancer Inst. 1995 Nov 1;87(21):1593-602. doi: 10.1093/jnci/87.21.1593. J Natl Cancer Inst. 1995. PMID: 7563202
-
Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.J Natl Cancer Inst. 1996 Oct 2;88(19):1383-92. doi: 10.1093/jnci/88.19.1383. J Natl Cancer Inst. 1996. PMID: 8827016
-
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.Oncotarget. 2016 Dec 13;7(50):83502-83513. doi: 10.18632/oncotarget.13148. Oncotarget. 2016. PMID: 27835872 Free PMC article. Review.
-
Proteins expressed in osteosarcoma and serum levels as prognostic factors.Int J Biochem Cell Biol. 2001 Jan;33(1):11-7. doi: 10.1016/s1357-2725(00)00066-2. Int J Biochem Cell Biol. 2001. PMID: 11167128 Review.
Cited by
-
Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.Vet Comp Oncol. 2015 Mar;13(1):48-59. doi: 10.1111/vco.12018. Epub 2013 Feb 15. Vet Comp Oncol. 2015. PMID: 23410058 Free PMC article.
-
MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines.Int J Mol Sci. 2023 May 2;24(9):8136. doi: 10.3390/ijms24098136. Int J Mol Sci. 2023. PMID: 37175843 Free PMC article.
-
Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines.Cancers (Basel). 2020 Apr 29;12(5):1117. doi: 10.3390/cancers12051117. Cancers (Basel). 2020. PMID: 32365663 Free PMC article.
-
Poly(ethylene glycol)-sheddable reduction-sensitive polyurethane micelles for triggered intracellular drug delivery for osteosarcoma treatment.J Orthop Translat. 2019 Dec 6;21:57-65. doi: 10.1016/j.jot.2019.11.001. eCollection 2020 Mar. J Orthop Translat. 2019. PMID: 32099805 Free PMC article.
-
Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma-In Vitro Studies.Molecules. 2021 Jun 8;26(12):3487. doi: 10.3390/molecules26123487. Molecules. 2021. PMID: 34201296 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials